These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
130 related items for PubMed ID: 7846741
1. Pharmacokinetics and pharmacodynamics of famotidine in children with gastroduodenal ulcers. Nagita A, Manago M, Aoki S, Mino M, Suzuki K, Ashida K. Ther Drug Monit; 1994 Oct; 16(5):444-9. PubMed ID: 7846741 [Abstract] [Full Text] [Related]
2. Pharmacokinetics and pharmacodynamics of famotidine in children. James LP, Marshall JD, Heulitt MJ, Wells TG, Letzig L, Kearns GL. J Clin Pharmacol; 1996 Jan; 36(1):48-54. PubMed ID: 8932543 [Abstract] [Full Text] [Related]
3. Maintenance of gastric pH above 6 with intravenous famotidine in patients with a bleeding duodenal ulcer. Delchier JC, el Amine I, Roudot-Thoraval F, Elouaer-Blanc L, Lamarque D, Stanescu L. Aliment Pharmacol Ther; 1995 Apr; 9(2):191-6. PubMed ID: 7605861 [Abstract] [Full Text] [Related]
14. Early and late effects of low-dose famotidine, ranitidine or placebo on pentagastrin-stimulated gastric acid secretion in man. Grimley CE, West JM, Loft DE, Cottrell J, Mann SG, Stauffer L, Nwokolo CU. Aliment Pharmacol Ther; 1996 Oct; 10(5):743-7. PubMed ID: 8899082 [Abstract] [Full Text] [Related]
15. Pharmacokinetics and pharmacodynamics of famotidine in paediatric patients. James LP, Kearns GL. Clin Pharmacokinet; 1996 Aug; 31(2):103-10. PubMed ID: 8853932 [Abstract] [Full Text] [Related]
16. Pharmacokinetics of famotidine in patients with cystic fibrosis. Maish WA, McCubbin MM, Letzig LG, Farrar HC, Kearns GL. J Clin Pharmacol; 1998 Nov; 38(11):1010-6. PubMed ID: 9824781 [Abstract] [Full Text] [Related]
17. [Pharmacokinetics and pharmacodynamics of two morphologically homogenous forms of famotidine per os in Chinese healthy volunteers]. Liu GL, Gao S, Wang SX, Shen WJ, Tan JQ. Zhongguo Yao Li Xue Bao; 1993 May; 14(3):257-9. PubMed ID: 8237405 [Abstract] [Full Text] [Related]
19. Statistical interpretation of the antisecretory effect of famotidine measured by intragastric pH-metry. Hunyady B, Juricskay I, Nagy L, Garamszegi M, Vincze A, Mózsik G. Eur J Clin Pharmacol; 1996 May; 50(6):449-56. PubMed ID: 8858270 [Abstract] [Full Text] [Related]
20. The effects of intermittent and continuous intravenous infusion of famotidine on gastric acidity in patients with peptic ulcers. Watanabe Y, Tsumura H, Sasaki H, Morimoto T. Clin Ther; 1990 May; 12(6):534-46. PubMed ID: 2289221 [Abstract] [Full Text] [Related] Page: [Next] [New Search]